![](/img/cover-not-exists.png)
2*FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses:
Falcone, A., Cremolini, C., Antoniotti, C., Lonardi, S., Ronzoni, M., Zaniboni, A., Tonini, G., Salvatore, L., Masi, G., Mezi, S., Tomasello, G., Carlomagno, C., Allegrini, G., Chiara, S., D'Amico, M.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv335.02
Date:
October, 2015
File:
PDF, 46 KB
english, 2015